SCHEMBL4950102

SCHEMBL4950102

CC(C)S(=O)(=O)Nc1ccsc1-c1ccc(-c2ccc(C(N)=O)cc2C#N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.41
STS P08842 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
GRM5 P41594 1/20 0.34
ROCK2 O75116 3/20 0.33
ROCK1 Q13464 3/20 0.33
PTGS2 P35354 2/20 0.32
CHEK2 O96017 1/20 0.32
DGAT1 O75907 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAP4K4 O95819 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4949007 0.91 GRM5 (0.36) PTGS1SCN5ASCN9AGRM5ROCK2
SCHEMBL4950754 0.89 SCN5A (0.37) PTGS1SCN5ASCN9AGRM5ROCK2
SCHEMBL4950116 0.88 PTGS1 (0.45) PTGS1PTGS2CHEK2MAP4K4
SCHEMBL5141284 0.88 SCN9A (0.47) SCN5ASCN9AGRM5ROCK2ROCK1
SCHEMBL4949577 0.83 ALDH1A1 (0.42) PTGS2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL4952472 0.83 F11 (0.35) PTGS1SCN9APTGS2KDM4EMAP4K4
SCHEMBL4952527 0.83 PTGS2 (0.36) PTGS1STSSCN9APTGS2LMNA
SCHEMBL4950027 0.78 TDP1 (0.39) PTGS1PTGS2KDM4E
SCHEMBL4950640 0.77 KDM4E (0.43) PTGS1PTGS2KDM4EPOLB
SCHEMBL4950017 0.77 EIF4E (0.39) PTGS1PTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893597-B1 AMPA RECEPTOR POTENTIATORS LILLY CO ELI (US) 2008-11-12 EP disclosed
US-7393868-B2 AMPA receptor potentiators ELI LILLY AND COMPANY (US) 2008-07-01 US disclosed
EP-1893597-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2008-03-05 EP disclosed
US-20070142441-A1 AMPA receptor potentiators ELI LILLY AND COMPANY 2007-06-21 US disclosed
WO-2006132811-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142441-A1 AMPA receptor potentiators GABRE, GRIN1, GRIK2 PTGS1 1216/4885STS 3389/4885SCN5A 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.